Prophase Labs Stock Performance
| PRPH Stock | USD 0.42 0.02 4.55% |
On a scale of 0 to 100, ProPhase Labs holds a performance score of 6. The company holds a Beta of 2.91, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ProPhase Labs will likely underperform. Please check ProPhase Labs' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether ProPhase Labs' historical price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ProPhase Labs are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, ProPhase Labs demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 2:1 | Dividend Date 2022-06-03 | Ex Dividend Date 2022-05-24 | Last Split Date 1997-01-23 |
1 | Acquisition by Gleckel Louis Md of 5564 shares of ProPhase Labs at 2.02 subject to Rule 16b-3 | 04/29/2025 |
2 | ProPhase Labs Q1 2025 Earnings Preview | 05/19/2025 |
3 | ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform | 06/06/2025 |
4 | ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart Test in Detecting Esophageal Cancer | 06/17/2025 |
5 | ProPhase Labs Secures 180-Day Extension to Meet Nasdaq Listing Requirements PRPH Stock News | 06/26/2025 |
6 | Why ENDRA Life Sciences Shares Are Trading Higher By Over 61 Here Are 20 Stocks Moving Premarket | 07/08/2025 |
7 | ProPhase Labs Inc. Stock Analysis and Forecast - Outperformance with explosive growth - Jammu Links News | 07/18/2025 |
8 | ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and ... | 07/21/2025 |
9 | ProPhase Labs Secures 3 Million in Convertible Note Financing PRPH Stock News | 07/23/2025 |
| Begin Period Cash Flow | 1.6 M | |
| Total Cashflows From Investing Activities | 2.4 M |
ProPhase Labs Relative Risk vs. Return Landscape
If you would invest 35.00 in ProPhase Labs on April 26, 2025 and sell it today you would earn a total of 7.00 from holding ProPhase Labs or generate 20.0% return on investment over 90 days. ProPhase Labs is currently generating 0.4804% in daily expected returns and assumes 5.9996% risk (volatility on return distribution) over the 90 days horizon. In different words, 53% of stocks are less volatile than ProPhase, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ProPhase Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProPhase Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ProPhase Labs, and traders can use it to determine the average amount a ProPhase Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0801
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PRPH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.0 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.48 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average ProPhase Labs is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProPhase Labs by adding it to a well-diversified portfolio.
ProPhase Labs Fundamentals Growth
ProPhase Stock prices reflect investors' perceptions of the future prospects and financial health of ProPhase Labs, and ProPhase Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ProPhase Stock performance.
| Return On Equity | -1.62 | ||||
| Return On Asset | -0.31 | ||||
| Operating Margin | (2.56) % | ||||
| Current Valuation | 31.99 M | ||||
| Shares Outstanding | 41.54 M | ||||
| Price To Earning | 6.59 X | ||||
| Price To Book | 1.20 X | ||||
| Price To Sales | 3.00 X | ||||
| Revenue | 6.77 M | ||||
| Gross Profit | 436 K | ||||
| EBITDA | (32.34 M) | ||||
| Net Income | (49.52 M) | ||||
| Cash And Equivalents | 27.5 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 24.57 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 4.20 X | ||||
| Book Value Per Share | 0.36 X | ||||
| Cash Flow From Operations | (17.54 M) | ||||
| Earnings Per Share | (2.23) X | ||||
| Market Capitalization | 17.51 M | ||||
| Total Asset | 63.2 M | ||||
| Retained Earnings | (58.39 M) | ||||
| Working Capital | (1.5 M) | ||||
| Current Asset | 9.73 M | ||||
| Current Liabilities | 6.25 M | ||||
About ProPhase Labs Performance
By evaluating ProPhase Labs' fundamental ratios, stakeholders can gain valuable insights into ProPhase Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ProPhase Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ProPhase Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 60.29 | 57.27 | |
| Return On Tangible Assets | (1.11) | (1.05) | |
| Return On Capital Employed | (1.24) | (1.18) | |
| Return On Assets | (0.84) | (0.80) | |
| Return On Equity | (7.26) | (6.89) |
Things to note about ProPhase Labs performance evaluation
Checking the ongoing alerts about ProPhase Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ProPhase Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ProPhase Labs had very high historical volatility over the last 90 days | |
| ProPhase Labs has some characteristics of a very speculative penny stock | |
| ProPhase Labs has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 6.77 M. Net Loss for the year was (49.52 M) with profit before overhead, payroll, taxes, and interest of 436 K. | |
| ProPhase Labs currently holds about 27.5 M in cash with (17.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: ProPhase Labs Secures 3 Million in Convertible Note Financing PRPH Stock News |
- Analyzing ProPhase Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ProPhase Labs' stock is overvalued or undervalued compared to its peers.
- Examining ProPhase Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ProPhase Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ProPhase Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ProPhase Labs' stock. These opinions can provide insight into ProPhase Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ProPhase Stock analysis
When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |